Script-free record · Release 2026-07-28.3
2023-HR-0119
Core facts and links below come from the same immutable public release as the enhanced record page.
measure
Measure at a glance
A resolution to urge the United States Food and Drug Administration to facilitate FDA regulated research on hyperbaric oxygen therapy for the treatment of Traumatic Brain Injury and Post Traumatic Stress Disorder.
- Legislative session
- 2023-2024
- Chamber
- house
- Measure type
- resolution
- First collected action
- 2023-06-08
- Latest collected action
- 2023-06-27
- Collection state
- parsed
- Official measure page
- Open official source ↗
Sponsorship, actions, and votes are documented relationships. They do not measure effort, authorship, influence, or work outside the published record.
Search journal and transcript mentions →
Passage search finds session-bounded text mentions of the printed identifier. A keyword match is not a verified relationship to this measure and may require source review.
Inspect all published fields
- Chamber
- house
- Detail state
- parsed
- First action date
- 2023-06-08
- Identifier
- 119
- Last action date
- 2023-06-27
- Measure id
- measure-14636
- Measure type
- resolution
- Object name
- 2023-HR-0119
- Prefix
- HR
- Session name
- 2023-2024
- Source url
- Open official source ↗
- Title
- A resolution to urge the United States Food and Drug Administration to facilitate FDA regulated research on hyperbaric oxygen therapy for the treatment of Traumatic Brain Injury and Post Traumatic Stress Disorder.
Follow the evidence
Cite this record
Michigan Legislative Activity and Evidence Dataset, release 2026-07-28.3, “2023-HR-0119,” /measures/measure-14636.
/api/v1/measures/measure-14636